Reward deficiency syndrome: genetic aspects of behavioral disorders.
暂无分享,去创建一个
D. Comings | K. Blum | D E Comings | K Blum
[1] J. Halikas,et al. Effects of regular marijuana use on sexual performance. , 1982, Journal of psychoactive drugs.
[2] M. Gill,et al. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children , 1999, Molecular Psychiatry.
[3] R. D. Hunt,et al. The Contribution of α2-Noradrenergic Mechanisms to Prefrontal Cortical Cognitive Function: Potential Significance for Attention-Deficit Hyperactivity Disorder , 1996 .
[4] D. Grandy,et al. D2 dopamine receptor gene and obesity. , 1994, The International journal of eating disorders.
[5] S. Steinhauer,et al. P300 amplitude decrements in children from families of alcoholic female probands , 1995, Biological Psychiatry.
[6] M Laruelle,et al. D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene , 1998, Molecular Psychiatry.
[7] J. Buxbaum,et al. Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test. , 1996, American journal of human genetics.
[8] E. Dawson. Identification of a highly polymorphic triplet repeat marker for the brain cannabinoid receptor gene: Use in linkage and association studies of schizophrenia , 1995, Schizophrenia Research.
[9] D. Saccuzzo,et al. Impaired speed of visual information processing in marijuana intoxication. , 1981, The American journal of psychiatry.
[10] N Risch,et al. The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal. , 1993, JAMA.
[11] R. Hare. Performance of psychopaths on cognitive tasks related to frontal lobe function. , 1984, Journal of abnormal psychology.
[12] C. R. Cloninger,et al. A psychobiological model of temperament and character. , 1993, Archives of general psychiatry.
[13] R. Tarter,et al. Differentiation of alcoholics. Childhood history of minimal brain dysfunction, family history, and drinking pattern. , 1977, Archives of general psychiatry.
[14] K. Merikangas,et al. Familial transmission of substance use disorders. , 1998, Archives of general psychiatry.
[15] C. Bowden,et al. Dopamine-beta-hydroxylase in behaviorally disturbed youth Relationship between teacher and parent ratings , 1993, Biological Psychiatry.
[16] D. Comings,et al. Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse , 1998, Molecular Psychiatry.
[17] D. Comings,et al. Additive effect of three noradrenergic genes (ADRA2A, ADRA2C, DBH) on attention‐deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects , 1999, Clinical genetics.
[18] D. Gibson,et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.
[19] W. Fratta,et al. Determination of methionine enkephalin in discrete regions of rat brain , 1977, Brain Research.
[20] L. Hollister,et al. Delta‐8‐ and delta‐9‐tetrahydrocannabinol; Comparison in man by oral and intravenous administration , 1973, Clinical pharmacology and therapeutics.
[21] D. Comings. Input from Our Readers , 1999, CNS Spectrums.
[22] G. Vaillant. Empirical studies of ego mechanisms of defense , 1986 .
[23] D. Comings,et al. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1. , 1996, American journal of medical genetics.
[24] C. Robert Cloninger,et al. Psychopathology in children of alcoholic and antisocial parents. , 1988, Alcoholism, clinical and experimental research.
[25] D. Comings,et al. The dopamine D2 receptor (DRD2) as a major gene in obesity and height. , 1993, Biochemical medicine and metabolic biology.
[26] J. Mattes. The role of frontal lobe dysfunction in childhood hyperkinesis. , 1980, Comprehensive psychiatry.
[27] R. Cadoret,et al. Genetic and environmental factors in alcohol abuse and antisocial personality. , 1987, Journal of studies on alcohol.
[28] L. L. Miller. Cannabis and the brain with special reference to the limbic system. , 1978, Advances in the biosciences.
[29] N Risch,et al. The Future of Genetic Studies of Complex Human Diseases , 1996, Science.
[30] M. Gill,et al. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism , 1997, Molecular Psychiatry.
[31] H. V. Van Tol,et al. Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor Variants , 1995, Journal of neurochemistry.
[32] J O Rinne,et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers , 1998, Molecular Psychiatry.
[33] D. Comings,et al. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.
[34] Allelic association of human dopamine D2 receptor gene in alcoholism. , 1990 .
[35] L. Oreland,et al. Low platelet monoamine oxidase activity in human alcoholics. , 1977, Medical biology.
[36] K. Kendler,et al. Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. , 1999, The American journal of psychiatry.
[37] Dragan M. Svrakic,et al. The Tridimensional Personality Questionnaire: U.S. Normative Data , 1991, Psychological reports.
[38] S. T. Mason,et al. Noradrenaline and selective attention: a review of the model and the evidence. , 1980, Life sciences.
[39] Comings De,et al. Tourette's syndrome and attention-deficit hyperactivity disorder: evidence for a genetic relationship. , 1993 .
[40] M. Nelen,et al. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. , 1993, Science.
[41] M. Davis,et al. Naltrexone blocks the post-shock increase of ethanol consumption. , 1986, Life sciences.
[42] R. Mechoulam,et al. Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .
[43] P. Seeman,et al. Multiple dopamine D4 receptor variants in the human population , 1992, Nature.
[44] A. von Knorring,et al. Platelet monoamine oxidase activity in type 1 and type 2 alcoholism. , 1991, Alcohol and alcoholism.
[45] C. Robert Cloninger,et al. Childhood personality predicts alcohol abuse in young adults. , 1988, Alcoholism, clinical and experimental research.
[46] D. Yurgelun-Todd,et al. The residual cognitive effects of heavy marijuana use in college students. , 1996, JAMA.
[47] R. Mark Wightman,et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.
[48] J. Lowinson,et al. Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. , 1995, Life sciences.
[49] M. Spitz,et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. , 1998, Journal of the National Cancer Institute.
[50] D. Bylund,et al. Platelet MAO activity and personality variations in normals , 1989, Psychiatry Research.
[51] J. Axelrod,et al. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[52] B. Diamond,et al. Enkephalins and nigrostriatal function , 1978, Neurology.
[53] S. Faraone,et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. , 1996, American journal of medical genetics.
[54] K. Buetow,et al. Cloning of the human dopamine D5 receptor gene and identification of a highly polymorphic microsatellite for the DRD5 locus that shows tight linkage to the chromosome 4p reference marker RAF1P1. , 1993, Genomics.
[55] R. Nicoll,et al. Enkephalin blocks inhibitory pathways in the vertebrate CNS , 1980, Nature.
[56] L. Siever,et al. D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects. , 1997, American journal of human genetics.
[57] A. Routtenberg. The reward system of the brain. , 1978, Scientific American.
[58] D. Grandy,et al. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. , 1989, American journal of human genetics.
[59] R. Ebstein,et al. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking , 1996, Nature Genetics.
[60] R. Cadoret,et al. Adoption study demonstrating two genetic pathways to drug abuse. , 1995, Archives of general psychiatry.
[61] G. Koob. Drugs of abuse: anatomy, pharmacology and function of reward pathways. , 1992, Trends in pharmacological sciences.
[62] D. Comings,et al. The D2 Dopamine Receptor Gene as a Determinant of Reward Deficiency Syndrome , 1996, Journal of the Royal Society of Medicine.
[63] G. Di Chiara,et al. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[64] Terrie E. Moffitt,et al. The neuropsychology of conduct disorder , 1993, Development and Psychopathology.
[65] C. Robert Cloninger,et al. Inheritance of risk to develop alcoholism. , 1986, NIDA research monograph.
[66] K. Blum,et al. Handbook of Psychiatric Genetics , 1996 .
[67] D. Murphy,et al. PSYCHOLOGICAL CORRELATES OF MONOAMINE OXIDASE ACTIVITY IN NORMALS , 1978, The Journal of nervous and mental disease.
[68] D. Comings,et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors , 1997, Molecular Psychiatry.
[69] F. Bloom,et al. Locomotor activation induced by infusion of endorphins into the ventral tegmental area: evidence for opiate-dopamine interactions. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[70] Association of the enkephalinase gene with low amplitude P300 waves. , 1999, Neuroreport.
[71] L. Stein,et al. Receptor subtypes in opioid and stimulant reward. , 1992, Pharmacology & toxicology.
[72] R. Wise,et al. Brain dopamine and reward. , 1989, Annual review of psychology.
[73] J. Glowinski,et al. Selective activation of the mesocortical DA system by stress , 1976, Nature.
[74] D. Brooks,et al. Evidence for striatal dopamine release during a video game , 1998, Nature.
[75] Peter Dayan,et al. A Neural Substrate of Prediction and Reward , 1997, Science.
[76] H. Y. Yang,et al. Regional distribution of leu and met enkephalin in rat brain , 1977, Neuropharmacology.
[77] S. S. St. Jeor,et al. D2 dopamine receptor gene and cigarette smoking: a reward gene? , 1994, Medical hypotheses.
[78] A. Cools,et al. Stimulant effects of enkephalin microinjection into the dopaminergic A10 area , 1979, Nature.
[79] D. Grandy,et al. Cloning and expression of a rat D2 dopamine receptor cDNA , 1988, Nature.
[80] Cloninger Cr. A systematic method for clinical description and classification of personality variants: A proposal. , 1987 .
[81] P Kocsis,et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. , 1991, JAMA.
[82] J. Halperin,et al. Noradrenergic mechanisms in ADHD children with and without reading disabilities: a replication and extension. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[83] Thomas J. H. Chen,et al. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. , 1996, Pharmacogenetics.
[84] P. Wood. Opioid regulation of CNS dopaminergic pathways: A review of methodology, receptor types, regional variations and species differences , 1983, Peptides.
[85] R. Wise,et al. A psychomotor stimulant theory of addiction. , 1987, Psychological review.
[86] G Saucier,et al. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. , 1999, American journal of medical genetics.
[87] A. Alterman,et al. Naltrexone in the treatment of alcohol dependence. , 1992, Archives of general psychiatry.
[88] Mccracken Jt. A two-part model of stimulant action on attention-deficit hyperactivity disorder in children. , 1991 .
[89] E. Gorenstein. Frontal lobe functions in psychopaths. , 1982, Journal of abnormal psychology.
[90] M. Le Moal,et al. Mesocorticolimbic dopaminergic network: functional and regulatory roles. , 1991, Physiological reviews.
[91] G. Uhl,et al. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. , 1992, Brain research. Molecular brain research.
[92] E P Noble,et al. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. , 1991, Archives of general psychiatry.
[93] W. Corrigall,et al. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area , 1994, Brain Research.
[94] Thomas J. H. Chen,et al. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. , 1995, Pharmacogenetics.
[95] D. Comings,et al. The clonidine patch and behavior problems. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.
[96] Pontius Aa. Dysfunction patterns analogous to frontal lobe system and caudate nucleus syndromes in some groups of minimal brain dysfunction. , 1973 .
[97] P. Sokoloff,et al. Dopamine-related genes and their relationships to monoamine metabolites in CSF , 1996, Biological Psychiatry.
[98] Hunt Rd. Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H. , 1987 .
[99] G. Bock,et al. The Biology of nicotine dependence , 1990 .
[100] J. Swanson,et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. , 1996, Molecular psychiatry.
[101] D. Comings. Why different rules are required for polygenic inheritance: lessons from studies of the DRD2 gene. , 1998, Alcohol.
[102] L. Miller. Neuropsychology of the aggressive psychopath: An integrative review , 1987 .
[103] H. Emrich,et al. Dopamine and the action of opiates: A reevaluation of the dopamine hypothesis of schizophrenia with special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia , 1985, Biological Psychiatry.
[104] D. Comings. Polygenic inheritance and micro/minisatellites , 1998, Molecular Psychiatry.
[105] K K Kidd,et al. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. , 1993, Human molecular genetics.
[106] F. Bloom,et al. Cellular and molecular mechanisms of drug dependence. , 1988, Science.
[107] R. Goldman,et al. Effect of cannabinoids on neurotransmitter uptake, atpase activity and morphology of mouse brain synaptosomes , 1977 .
[108] Camillo Ricordi,et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes , 1997, Nature Genetics.
[109] A. Arnsten,et al. Catecholamine regulation of the prefrontal cortex , 1997, Journal of psychopharmacology.
[110] D. Comings. Tourette Syndrome and Human Behavior , 1990 .
[111] D. Comings,et al. Cannabinoid receptor gene (CNR1): association with IV drug use , 1997, Molecular Psychiatry.
[112] J. McCracken,et al. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.
[113] H. Begleiter,et al. Event-related brain potentials in boys at risk for alcoholism. , 1984, Science.
[114] G. Di Chiara,et al. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. , 1997, Science.
[115] D. Comings,et al. Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density , 1999, Molecular Psychiatry.
[116] N J Cox,et al. Association of attention-deficit disorder and the dopamine transporter gene. , 1995, American journal of human genetics.
[117] H. Gurling,et al. The D2 Dopamine Receptor Gene and Alcoholism: A Genetic Effect in the Liability for Alcoholism , 1994, Journal of the Royal Society of Medicine.
[118] James L Olds,et al. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. , 1954, Journal of comparative and physiological psychology.
[119] B. Winblad,et al. LOWERED MONOAMINE OXIDASE ACTIVITY IN BRAINS FROM ALCOHOLIC SUICIDES , 1975, Journal of neurochemistry.
[120] R. D. Hunt,et al. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. , 1985, Journal of the American Academy of Child Psychiatry.
[121] T. Belin,et al. D2 and D4 dopamine receptor polymorphisms and personality. , 1998, American journal of medical genetics.
[122] M. Posner,et al. The attention system of the human brain. , 1990, Annual review of neuroscience.
[123] F. Bloom,et al. Meta-analysis of P300 amplitude from males at risk for alcoholism , 1994 .
[124] D. Comings,et al. Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes , 2000, Clinical genetics.
[125] J. Scheel-Krüger,et al. Diethyldithiocarbamate and amphetamine stereotype behaviour , 1966, The Journal of pharmacy and pharmacology.
[126] C. Robert Cloninger,et al. Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes. , 1993, American journal of medical genetics.
[127] John G. Cull,et al. REWARD DEFICIENCY SYNDROME , 1996 .
[128] F. J. Kelly,et al. Intelligence and Delinquency: A Reconsideration , 1963 .
[129] M. Caron,et al. A mouse knockout , 1996 .
[130] D. Comings,et al. Association between the cannabinoid receptor gene (CNR1) and the P300 event-related potential , 1997, Molecular Psychiatry.
[131] N G Waller,et al. The Tridimensional Personality Questionnaire: Structural Validity and Comparison with the Multidimensional Personality Questionnaire. , 1991, Multivariate behavioral research.
[132] G. Di Chiara,et al. Neurobiology of opiate abuse. , 1992, Trends in pharmacological sciences.
[133] J. Wu,et al. D2 dopamine receptor polymorphism and brain regional glucose metabolism. , 1997, American journal of medical genetics.
[134] M. Javors,et al. Attention deficit disorder symptoms and urine catecholamines , 1989, Psychiatry Research.
[135] D. Comings,et al. Molecular heterosis Implications for complex inheritance , 1997 .
[136] J. Halperin,et al. Plasma Catecholamine Metabolite Levels in ADHD Boys With and Without Reading Disabilities , 1993 .
[137] P. Clarke,et al. Mesolimbic dopamine activation--the key to nicotine reinforcement? , 2007, Ciba Foundation symposium.
[138] A. Howlett,et al. Pharmacology of cannabinoid receptors. , 1995, Annual review of pharmacology and toxicology.
[139] M. Anglin,et al. The D2 dopamine receptor gene, addiction, and personality: clinical correlates in cocaine abusers , 1996, Biological Psychiatry.